U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07355634) titled 'Terraflora Daily Care and Gastrointestinal Health' on Jan. 02.
Brief Summary: A 12-week, randomized, double-blind, placebo-controlled clinical trial will be conducted evaluating the effectiveness of Enviromedica - Terraflora Daily Care on markers of gastrointestinal function and symptoms.
Study Start Date: Jan., 2026
Study Type: INTERVENTIONAL
Condition:
Gastrointestinal
Intervention:
DIETARY_SUPPLEMENT: Synbiotic Dietary Supplement
12 weeks of supplementation with Enviromedica - Terraflora Daily Care
DIETARY_SUPPLEMENT: Placebo
Placebo capsule
Recruitment Status: NOT_YET_RECRUITING
Sponsor: OvationLab
Disclaimer: Curate...